Sidney Chan - ALR Technologies CEO, Chairman
ALRTF Stock | 0.01 0 9.91% |
Insider
Sidney Chan is CEO, Chairman of ALR Technologies
Age | 73 |
Phone | 804 554 3500 |
Web | https://www.alrt.com |
ALR Technologies Management Efficiency
The company has return on total asset (ROA) of (8.7276) % which means that it has lost $8.7276 on every $100 spent on assets. This is way below average. ALR Technologies' management efficiency ratios could be used to measure how well ALR Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Lori Winkler | Zimmer Biomet Holdings | 62 | |
Andrew Pierce | Stryker | 50 | |
Nitin Goyal | Zimmer Biomet Holdings | N/A | |
Alan Douville | Stryker | N/A | |
Daveen Chopra | Edwards Lifesciences Corp | 45 | |
Brett Wall | Medtronic PLC | 58 | |
Sean Christensen | DexCom Inc | N/A | |
Catherine Jennings | Boston Scientific Corp | N/A | |
Marc Koebernick | Siemens Healthineers AG | N/A | |
Gregory Ahlberg | Abbott Laboratories | 54 | |
Brad Lerman | Medtronic PLC | 63 | |
Michael Pederson | Abbott Laboratories | 59 | |
Louis Morrone | Abbott Laboratories | 44 | |
Lisa Earnhardt | Abbott Laboratories | 54 | |
J Pierce | Stryker | 47 | |
Sean Carney | Koninklijke Philips NV | N/A | |
Carsten Bertram | Siemens Healthineers AG | N/A | |
Paul Flynn | DexCom Inc | 55 | |
Andre Hartung | Siemens Healthineers AG | N/A | |
Didier Deltort | Zimmer Biomet Holdings | 52 | |
Carrie Nichol | Zimmer Biomet Holdings | 40 |
Management Performance
Return On Asset | -8.73 |
ALR Technologies Leadership Team
Elected by the shareholders, the ALR Technologies' board of directors comprises two types of representatives: ALR Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ALR. The board's role is to monitor ALR Technologies' management team and ensure that shareholders' interests are well served. ALR Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ALR Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Joe Stern, Head Health | ||
Barbara Dubiel, Consultant | ||
John Tolentino, Consultant | ||
Jacqueline Wu, Head Marketing | ||
III MD, Medical Consultant | ||
Sidney Chan, CEO, Chairman | ||
Mark Uy, Consultant | ||
Johnny Tlardera, Consultant | ||
Barrett Ehrlich, Consultant |
ALR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is ALR Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -8.73 | |||
Operating Margin | (390.28) % | |||
Current Valuation | 51.54 M | |||
Shares Outstanding | 551.97 M | |||
Shares Owned By Insiders | 69.70 % | |||
Price To Sales | 3,460 X | |||
Revenue | 7.47 K | |||
Gross Profit | 4.95 K | |||
EBITDA | (6.4 M) | |||
Net Income | (8.44 M) |
Currently Active Assets on Macroaxis
Other Information on Investing in ALR OTC Stock
ALR Technologies financial ratios help investors to determine whether ALR OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALR with respect to the benefits of owning ALR Technologies security.